L6U-60847-26239
3 vaccinations
1 coded response
23 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 037 / NH
- Registered
- 2022-06-26
- Relationship
- Child or adolescent in my care
- Guardian
- DCX-33902-92374
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-26
Registered in v-safe
-
2022-08-30
Dose 1 — Pfizer-BioNTech
- 2022-08-30
-
2022-08-31
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Loss of appetiteUnder 3 check-in
-
2022-09-01
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-09-02
- 2022-09-03
-
2022-09-04
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Sleepiness, DiarrheaUnder 3 check-in
- 2022-09-05
- 2022-09-06
- 2022-09-20
-
2022-09-28
Dose 2 — Pfizer-BioNTech
- 2022-09-28
-
2022-09-29
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-04
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
-
2022-11-28
Dose 3 — Pfizer-BioNTech
-
2022-12-28
Survey response — 3 months, dose 2, under 3MedDRA: Conjunctivitis bacterial, Ear infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Ear infection and bacterial conjunctivitis.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-28
Report sent to call center — 3 months, dose 2, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-29
- 2023-05-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-30 | Pfizer-BioNTech | No |
| 2 | 2022-09-28 | Pfizer-BioNTech | No |
| 3 | 2022-11-28 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Ear infection and bacterial conjunctivitis.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis bacterial | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release